FDA’s Postmarket Cybersecurity Guidance Is Due for an Update.
October 26, 2026
What Changes When Your Devices Are Already in the Field By Ken Zalevsky, VP and GM, C2A Security A revision would likely do more than
" " indicates required fields
What Changes When Your Devices Are Already in the Field By Ken Zalevsky, VP and GM, C2A Security A revision would likely do more than
Jerusalem, Israel, August 25, 2026 — C2A Security, the only context and AI-driven product security orchestration platform addressing the needs of software-defined products and cyber-physical
Five agencies, the Siemens S7 advisory, and the product security question underneath it On August 19, 2026, five U.S. federal agencies signed the same document.
Lubadel brings more than 25 years of healthcare technology, product security and regulatory experience to support C2A Security’s strategy across medical devices and other cyber-physical
The future belongs to systems that can prove provenance, context and chain of custody. The Growing Challenge of Digital Trust Artificial intelligence is changing the
John brings extensive automotive, OEM, supplier, and cybersecurity leadership experience from companies like Porsche, Volkswagen, and Rivian to help shape C2A Security’s roadmap across multiple
Following a Successful Proof of Concept, Triumph Commits to the Long-Term Deployment of the EVSec Platform Across Its Product Security Lifecycle JERUSALEM, Israel, July 28,
A seasoned sales executive in the cybersecurity sector, John will lead the company’s revenue strategy as it enters a new growth phase Jerusalem, Israel, September
Why The New FDA Update Matters Right Now for MDMs The FDA’s Final Cybersecurity Guidance of June 2025 introduces significant new requirements under the FD&C
